A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of Etoreat (Etodolac-Lidocaine Topical Patch) in the Treatment of Acute Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2018
Price : $35 *
At a glance
- Drugs Etodolac/lidocaine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors IL Pharma
- 06 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 29 Oct 2013 New trial record